Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Cancer|December 23, 2014
A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profileRegina Heidenreich, Edith Jasny, Aleksandra Kowalczyk, et al.
Vaccine|February 25, 2019
RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trialFatma Doener, Henoch S Hong, Ingo Meyer, et al.
Human Vaccines & Immunotherapeutics|August 8, 2013
A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccinesKarl-Josef Kallen, Regina Heidenreich, Margit Schnee, et al.
NPJ Vaccines|December 22, 2017
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccinesJohannes Lutz, Sandra Lazzaro, Mohamed Habbeddine, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2009
Signaling mechanism of extracellular RNA in endothelial cellsSilvia Fischer, Miwako Nishio, Saskia C Peters, et al.
EMBO Molecular Medicine|August 11, 2017
mRNA mediates passive vaccination against infectious agents, toxins, and tumorsMoritz Thran, Jean Mukherjee, Marion Pönisch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2017
A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent EffectsAnnett Ziegler, Claudia Soldner, Stefan Lienenklaus, et al.
BMC Cancer|October 8, 2014
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancerMartin Sebastian, Alexandros Papachristofilou, Christian Weiss, et al.
Circulation|June 24, 2004
Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosisDirk H Walter, Manfred Cejna, Larry Diaz-Sandoval, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2022
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular CarcinomaMarkus W Löffler, Stefania Gori, Francesco Izzo, et al.
Pageof 3